Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$230.00K$230.00Kderived+72.9% vs Q4 2014 Net Income-$1.87M-$1.87MderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,874,000N/M Operating Cash Flowderived-$1,203,000N/M Free Cash Flowderived-$1,203,000N/M Margins · derivedOperating margin-814.8%+1189.0 pt vs Q4 2014
Net margin-811.3%+1200.0 pt vs Q4 2014
ended Jul 31, 2015 · filed Oct 28, 2015 · 89 d after period end